PJ Pisella, P Pouliquen, C Baudouin - British journal of Ophthalmology, 2002 - bjo.bmj.com Results: 84% patients used P, 13% received PF, and 3% a combination of P and PF eye
drops. All symptoms were more prevalent with P than with PF drops (p<0.001): discomfort upon
instillation (43% versus 17%), and symptoms between instillations such as ... Cited by 91 - Related articles - BL Direct - All 9 versions
C Baudouin, PJ Pisella, K Fillacier, M Goldschild, F … - Ophthalmology, 1999 - Elsevier To investigate conjunctival and trabecular specimens from patients with glaucoma according
to the duration and number of drugs received before filtration surgery, and to confirm, in a complementary
experimental model, the role of preservative by comparing the effects of preserved and ... Cited by 128 - Related articles - BL Direct - All 10 versions
- ►iovs.org PJ Pisella, C Debbasch, P Hamard, C Creuzot- … - … ophthalmology & visual …, 2004 - ARVO METHODS. Impression cytology (IC) specimens were obtained from a series of normal subjects
and from patients with glaucoma treated for at least 1 year with latanoprost eye drops or preserved
or unpreserved timolol. All groups were comparable in age and duration of treatment. ... Cited by 74 - Related articles - BL Direct - All 4 versions
M De Saint Jean, C Debbasch, F Brignole, P … - Current eye …, 2000 - informahealthcare.com M. De Saint Jean1, C. Debbasch2, F. Brignole3, P. Rat2, JM. Warnet2, and C. Baudouin1 ...
Departments of 1Ophthalmology and 3Immunohematology, Ambroise Paré Hospital, University
Paris 5, Boulogne, France; 2Department of Pharmacotoxicology2, XV-XX Hospital, Paris, ... Cited by 71 - Related articles - BL Direct - All 8 versions
- ►iovs.org [PDF] M De Saint Jean, F Brignole, AF Bringuier, A Bauchet … - … ophthalmology & visual …, 1999 - ARVO Magdalena De Saint Jean, 13 Frangoise Brignole, 2 Anne-France Bringuier, 1 ... Alain
Bauchet, 4 Gerard Feldmann, 1 and Christophe Baudouin^ ... PURPOSE. The aim of this study
was to investigate the action of benzalkonium chloride (BAC), used as a preservative in ... Cited by 105 - Related articles - BL Direct - All 3 versions
JM Herreras, JC Pastor, M Calonge, VM … - Ophthalmology(Rochester …, 1992 - cat.inist.fr Ocular surface alteration after long-term treatment with an antiglaucomatous drug.
JM HERRERAS, JC PASTOR, M CALONGE, VM ARSENSIO Ophthalmology(
Rochester, MN) 99:77, 1082-1088, Elsevier, 1992. Background ... Cited by 106 - Related articles - All 4 versions
- ►bmj.com C Baudouin, C de Lunardo - British Medical Journal, 1998 - bjo.bmj.com However, little is known concerning the accurate mechanisms of such toxic side effects in long
term and/or multitreated glaucoma patients. Is the active drug responsible, as suggested by the
significant toxicity demonstrated by adrenalin derivatives? Is it the preservative, ... Cited by 64 - Related articles - BL Direct - All 7 versions
DC Broadway, I Grierson, C O'Brien, RA … - Archives of …, 1994 - archopht.highwire.org Methods: Filtration surgery was performed in 124 patients (trabeculectomy in 112 and triple procedures
[trabeculectomy, cataract extraction, and intraocular lens implantation] in 12), and the outcome
of these procedures was assessed after a minimum follow-up of 6 months. A conjunctival ... Cited by 156 - Related articles - BL Direct - All 4 versions
